Lensar LNSR
NASDAQ LNSR
$6.71 -0.19 (-2.75%)
As of: Sep 30, 2026 · 3:56 PM EDT

Lensar (LNSR) Non-Current Debt (2026)

Updated

Lensar's Non-Current Debt came in at $3.75 million for Q2 2026, down 25.0% from the prior quarter.

Analysis

Lensar (LNSR) Non-Current Debt (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 39.18 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 29.60 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 25.15 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn -
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 25.62 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 14.19 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 10.92 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 598.70 Mn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 13.51 Bn
10 Lensar 84.75 Mn 36.62 Mn 9.78 Mn 3.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.75 Mn
Mar 31, 2026 5.00 Mn
API Access

Lensar Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=LNSR&period=max&api_key=YOUR_API_KEY